Particle size control of detergents in mixed flow spray dryers

Particle size is a key quality parameter of a powder detergent as it determines its performance, the bulk density and the look and feel of the product. Consequently, it is essential that particle size is controlled to ensure the consistency of performance when comparing new formulations. The majority of study reported in the literature relating to particle size control, focuses on the spray produced by the atomisation technique. One approach advocated to achieve particle size control is the manipulation of the ratio of the mass slurry rate and mass flow rate of gas used for atomisation. Within this study, ratio control was compared with an automatic cascade loop approach using online measurements of the powder particle size on a small-scale pilot plant. It was concluded that cascade control of the mean particle size, based on manipulating the mass flow rate of gas, resulted in tighter, more responsive control. The effect of a ratio change varied with different formulations and different slurry rates. Furthermore, changes in slurry rate caused complications, as the impact on particle size growth in the dryer is non-linear and difficult to predict. The cascade loop enables further study into the effect of particle size on detergent performance

Engineered immunogens to elicit antibodies against conserved coronavirus epitopes

Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues 815-823 adjacent to the fusion peptide, are highly conserved across sarbecoviruses and are recognized by broadly reactive antibodies, providing hope that vaccines targeting these epitopes could offer protection against both current and emergent viruses. Here we employ computational modeling to design scaffolded immunogens that display the spike 815-823 peptide and the stem helix epitopes without the distracting and immunodominant receptor binding domain. These engineered proteins bind with high affinity and specificity to the mature and germline versions of previously identified broadly protective human antibodies. Epitope scaffolds interact with both sera and isolated monoclonal antibodies with broadly reactivity from individuals with pre-existing SARS-CoV-2 immunity. When used as immunogens, epitope scaffolds elicit sera with broad betacoronavirus reactivity and protect as “boosts” against live virus challenge in mice, illustrating their potential as components of a future pancoronavirus vaccine

Whole bone marrow transplantation induces angiogenesis following acute ischemia

10.1179/135100002125000532Redox Report74215-218RDRP

Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: A "vasoconstrictor" with a unique hemodynamic profile

American Journal of Physiology - Heart and Circulatory Physiology2863 55-3AJPP